AstraZeneca booster dose works against Omicron, says Oxford lab study
The University of Oxford, in collaboration with AstraZeneca, has announced interim trial data from its Phase III trials that show its candidate coronavirus vacc
Stay updated with breaking news from Full Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The University of Oxford, in collaboration with AstraZeneca, has announced interim trial data from its Phase III trials that show its candidate coronavirus vacc
1 1Madda Walabu University Goba Referral Hospital, School of Health Sciences, Department of Public Health, Bale, Ethiopia; 2Madda Walabu University Goba Referral Hospital, School of Medicine, Department of Physiology, Bale, Ethiopia; 3Madda Walabu University Goba Referral Hospital, School of Medicine, Department of Anatomy, Bale, Ethiopia Background: Incomplete vaccination can put children at greater risk of acquiring vaccine-preventable diseases. In Ethiopia, vaccination coverage against vaccine-preventable diseases is still a significant and persistent public health challenge. Thus, the a...